MoneyWorks4Me

Sai Life Sciences - Quaterly Results

06 Feb 2025 Evaluate
The December 2024 quarter revenue stood at Rs. 4286.02 millions, up 15.03% as compared to Rs. 3725.96 millions during the corresponding quarter last year.A good growth in profit of 27.08% reported to Rs. 510.57  millions over Rs. 401.78 millions of corresponding previous quarter.Operating profit for the quarter ended December 2024 rose to 1206.42 millions as compared to 1041.31 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202412 202312 % Var
Sales 4286.02 3725.96 15.03 4286.02 3725.96 15.03 4286.02 3725.96 15.03
Other Income 94.48 106.12 -10.97 94.48 106.12 -10.97 94.48 106.12 -10.97
PBIDT 1206.42 1041.31 15.86 1206.42 1041.31 15.86 1206.42 1041.31 15.86
Interest 216.59 217.03 -0.20 216.59 217.03 -0.20 216.59 217.03 -0.20
PBDT 989.83 824.28 20.08 989.83 824.28 20.08 989.83 824.28 20.08
Depreciation 310.70 283.04 9.77 310.70 283.04 9.77 310.70 283.04 9.77
PBT 679.13 541.24 25.48 679.13 541.24 25.48 679.13 541.24 25.48
TAX 168.56 139.46 20.87 168.56 139.46 20.87 168.56 139.46 20.87
Deferred Tax 69.54 106.54 -34.73 69.54 106.54 -34.73 69.54 106.54 -34.73
PAT 510.57 401.78 27.08 510.57 401.78 27.08 510.57 401.78 27.08
Equity 207.99 180.40 15.29 207.99 180.40 15.29 207.99 180.40 15.29
PBIDTM(%) 28.15 27.95 0.72 28.15 27.95 0.72 28.15 27.95 0.72
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..